| 000 | 01730 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514053003.0 | ||
| 264 | 0 | _c20030617 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/s0960-894x(02)00833-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArvanitis, Argyrios G | |
| 245 | 0 | 0 |
_aImidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cJan 2003 |
||
| 300 |
_a125-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aAnxiety Disorders _xdrug therapy |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 |
_aPyridines _xchemical synthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Corticotropin-Releasing Hormone _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aRescinito, Joseph T | |
| 700 | 1 | _aArnold, Charles R | |
| 700 | 1 | _aWilde, Richard G | |
| 700 | 1 | _aCain, Gary A | |
| 700 | 1 | _aSun, Jung Hui | |
| 700 | 1 | _aYan, Jia-Sheng | |
| 700 | 1 | _aTeleha, Christopher A | |
| 700 | 1 | _aFitzgerald, Lawrence W | |
| 700 | 1 | _aMcElroy, John | |
| 700 | 1 | _aZaczek, Robert | |
| 700 | 1 | _aHartig, Paul R | |
| 700 | 1 | _aGrossman, Scott | |
| 700 | 1 | _aArneric, Stephen P | |
| 700 | 1 | _aGilligan, Paul J | |
| 700 | 1 | _aOlson, Richard E | |
| 700 | 1 | _aRobertson, David W | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 13 _gno. 1 _gp. 125-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-894x(02)00833-8 _zAvailable from publisher's website |
| 999 |
_c12272870 _d12272870 |
||